130 related articles for article (PubMed ID: 29534996)
1. Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.
Raymond EG; Shochet T; Bracken H
Contraception; 2018 Jul; 98(1):30-35. PubMed ID: 29534996
[TBL] [Abstract][Full Text] [Related]
2. Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.
Raymond EG; Shochet T; Blum J; Sheldon WR; Platais I; Bracken H; Dabash R; Weaver MA; Ngoc NTN; Blumenthal PD; Winikoff B
Contraception; 2017 May; 95(5):442-448. PubMed ID: 28041991
[TBL] [Abstract][Full Text] [Related]
3. Self-assessment of medical abortion outcome using symptoms and home pregnancy testing.
Raymond EG; Tan YL; Grant M; Benavides E; Reis M; Sacks DN; Hannum C; Frapp S; Weaver MA
Contraception; 2018 Apr; 97(4):324-328. PubMed ID: 29242085
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial assessing home use of two pregnancy tests for determining early medical abortion outcomes at 3, 7 and 14days after mifepristone.
Blum J; Sheldon WR; Ngoc NT; Winikoff B; Nga NT; Martin R; Van Thanh L; Blumenthal PD
Contraception; 2016 Aug; 94(2):115-21. PubMed ID: 27067706
[TBL] [Abstract][Full Text] [Related]
5. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
Faucher P; Baunot N; Madelenat P
Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
[TBL] [Abstract][Full Text] [Related]
6. Comparison of two low-sensitivity urine pregnancy tests for confirming the success of early medical abortion.
Millar SL; Cameron ST
BMJ Sex Reprod Health; 2018 Jan; 44(1):54-57. PubMed ID: 29175838
[TBL] [Abstract][Full Text] [Related]
7. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
[TBL] [Abstract][Full Text] [Related]
8. Mifepristone and misoprostol for early abortion when no gestational sac is present.
Schaff EA; Fielding SL; Eisinger S; Stadalius L
Contraception; 2001 May; 63(5):251-4. PubMed ID: 11448464
[TBL] [Abstract][Full Text] [Related]
9. Can at-home semi-quantitative pregnancy tests serve as a replacement for clinical follow-up of medical abortion? A US study.
Blum J; Shochet T; Lynd K; Lichtenberg ES; Fischer D; Arnesen M; Winikoff B; Blumenthal PD
Contraception; 2012 Dec; 86(6):757-62. PubMed ID: 22895097
[TBL] [Abstract][Full Text] [Related]
10. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses.
Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E
Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147
[TBL] [Abstract][Full Text] [Related]
11. At-home urine pregnancy test assessment after mifepristone and misoprostol for undesired pregnancy of unknown location.
Gilbert AL; Gelfand D; Fortin J; Roncari D; Goldberg AB
Contraception; 2023 Apr; 120():109955. PubMed ID: 36634731
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.
Hassoun D; Périn I; Hiên H; Demars HH
Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of telephone follow-up after medical abortion.
Perriera LK; Reeves MF; Chen BA; Hohmann HL; Hayes J; Creinin MD
Contraception; 2010 Feb; 81(2):143-9. PubMed ID: 20103453
[TBL] [Abstract][Full Text] [Related]
14. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
[TBL] [Abstract][Full Text] [Related]
15. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
[TBL] [Abstract][Full Text] [Related]
16. Acceptability and feasibility of phone follow-up with a semiquantitative urine pregnancy test after medical abortion in Moldova and Uzbekistan.
Platais I; Tsereteli T; Comendant R; Kurbanbekova D; Winikoff B
Contraception; 2015 Feb; 91(2):178-83. PubMed ID: 25497383
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
18. Double-blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation.
Bartley J; Brown A; Elton R; Baird DT
Hum Reprod; 2001 Oct; 16(10):2098-102. PubMed ID: 11574498
[TBL] [Abstract][Full Text] [Related]
19. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
[TBL] [Abstract][Full Text] [Related]
20. Can women accurately assess the outcome of medical abortion based on symptoms alone?
Jackson AV; Dayananda I; Fortin JM; Fitzmaurice G; Goldberg AB
Contraception; 2012 Feb; 85(2):192-7. PubMed ID: 22067786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]